EWTX
Edgewise Therapeutics Inc
NASDAQ: EWTX · HEALTHCARE · BIOTECHNOLOGY
$30.45
-1.74% today
Updated 2026-04-29
Market cap
$3.27B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.63
Dividend yield
—
52W range
$12 – $35
Volume
0.9M
Edgewise Therapeutics Inc (EWTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.17M | $-14.63M | $-33.51M | $-52.63M | $-91.95M | $-109.03M | $-143.82M |
| Capital expenditures | $180000.00 | $203000.00 | $668000.00 | $5.55M | $5.75M | $1.31M | $256000.00 |
| Depreciation | $123000.00 | $185000.00 | $272000.00 | $538000.00 | $1.73M | $2.29M | — |
| Stock-based comp | $77000.00 | $354000.00 | $4.40M | $10.92M | $17.56M | $24.71M | $34.75M |
| Free cash flow | $-9.35M | $-14.84M | $-34.17M | $-58.18M | $-97.69M | $-110.34M | $-144.07M |
| Investing cash flow | $-180000.00 | $-24.38M | $-242.23M | $-70.58M | $102.89M | $-184.66M | — |
| Financing cash flow | $24.80M | $120.28M | $186.38M | $129.64M | $53.17M | $249.25M | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-89.35M | $6.43M | — | — | — |